MSCI [MSCI] vs CME [CME] Detailed Stock Comparison
MSCI
NYSE
Loading...
CME
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: MSCI wins in 6 metrics, CME wins in 14 metrics, with 0 ties. CME appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | MSCI | CME | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 36.77 | 26.52 | CME |
| Price-to-Book Ratio | -49.88 | 3.55 | MSCI |
| Debt-to-Equity Ratio | -5.25 | 13.60 | MSCI |
| PEG Ratio | 2.25 | 1.70 | CME |
| EV/EBITDA | 27.38 | 22.08 | CME |
| Profit Margin (TTM) | 39.46% | 58.59% | CME |
| Operating Margin (TTM) | 54.55% | 66.87% | CME |
| EBITDA Margin (TTM) | 54.55% | 66.87% | CME |
| Return on Equity | -117.99% | 13.61% | CME |
| Return on Assets (TTM) | 18.55% | 1.74% | MSCI |
| Free Cash Flow (TTM) | $1.39B | $3.60B | CME |
| Dividend Yield | 0.92% | 4.30% | CME |
| 1-Year Return | 0.64% | 30.17% | CME |
| Price-to-Sales Ratio (TTM) | 14.39 | 15.35 | MSCI |
| Enterprise Value | $47.30B | $100.39B | CME |
| EV/Revenue Ratio | 15.84 | 15.61 | CME |
| Gross Profit Margin (TTM) | 82.18% | 86.90% | CME |
| Revenue per Share (TTM) | $38 | $18 | MSCI |
| Earnings per Share (Diluted) | $15.11 | $10.33 | MSCI |
| Beta (Stock Volatility) | 1.29 | 0.46 | CME |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
MSCI vs CME Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| MSCI | 1.33% | 3.20% | 9.18% | 1.94% | 0.22% | -3.73% |
| CME | -1.39% | -1.61% | -1.86% | -4.43% | 8.79% | 15.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| MSCI | 0.64% | 25.94% | 53.83% | 824.76% | 1,785.31% | 2,203.00% |
| CME | 30.17% | 37.27% | 52.25% | 184.84% | 424.87% | 400.97% |
Performance & Financial Health Analysis: MSCI vs CME
| Metric | MSCI | CME |
|---|---|---|
| Market Information | ||
| Market Cap | $42.99B | $98.72B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 642,820 | 1,887,200 |
| 90 Day Avg. Volume | 861,290 | 2,111,473 |
| Last Close | $574.83 | $269.52 |
| 52 Week Range | $486.74 - $642.45 | $206.44 - $290.79 |
| % from 52W High | -10.53% | -7.31% |
| All-Time High | $679.85 (Nov 15, 2021) | $290.79 (Jun 02, 2025) |
| % from All-Time High | -15.45% | -7.31% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.10% |
| Quarterly Earnings Growth | 0.14% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | 0.39% | 0.59% |
| Operating Margin (TTM) | 0.55% | 0.67% |
| Return on Equity (TTM) | -1.18% | 0.14% |
| Debt to Equity (MRQ) | -5.25 | 13.60 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-11.46 | $77.13 |
| Cash per Share (MRQ) | $4.44 | $5.82 |
| Operating Cash Flow (TTM) | $1.49B | $4.20B |
| Levered Free Cash Flow (TTM) | $1.12B | $2.92B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.92% | 4.30% |
| Last 12-Month Dividend | $5.00 | $11.85 |
Valuation & Enterprise Metrics Analysis: MSCI vs CME
| Metric | MSCI | CME |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 36.77 | 26.52 |
| Forward P/E | 32.61 | 26.41 |
| PEG Ratio | 2.25 | 1.70 |
| Price to Sales (TTM) | 14.39 | 15.35 |
| Price to Book (MRQ) | -49.88 | 3.55 |
| Market Capitalization | ||
| Market Capitalization | $42.99B | $98.72B |
| Enterprise Value | $47.30B | $100.39B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 15.84 | 15.61 |
| Enterprise to EBITDA | 27.38 | 22.08 |
| Risk & Other Metrics | ||
| Beta | 1.29 | 0.46 |
| Book Value per Share (MRQ) | $-11.46 | $77.13 |
Financial Statements Comparison: MSCI vs CME
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MSCI | CME |
|---|---|---|
| Revenue/Sales | $745.83M | $1.64B |
| Cost of Goods Sold | $136.79M | $206.70M |
| Gross Profit | $609.04M | $1.44B |
| Research & Development | $47.59M | N/A |
| Operating Income (EBIT) | $377.02M | $1.11B |
| EBITDA | $432.11M | $476.30M |
| Pre-Tax Income | $331.07M | $1.24B |
| Income Tax | $42.47M | $288.60M |
| Net Income (Profit) | $288.60M | $956.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MSCI | CME |
|---|---|---|
| Cash & Equivalents | $343.68M | $1.41B |
| Total Current Assets | $1.27B | $123.45B |
| Total Current Liabilities | $1.47B | $121.42B |
| Long-Term Debt | $4.63B | $3.42B |
| Total Shareholders Equity | $-886.21M | $27.03B |
| Retained Earnings | $5.09B | $4.69B |
| Property, Plant & Equipment | $202.79M | $371.20M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MSCI | CME |
|---|---|---|
| Operating Cash Flow | $308.74M | $838.30M |
| Capital Expenditures | N/A | $-14.20M |
| Free Cash Flow | $301.58M | $1.10B |
| Debt Repayment | $-149.88M | $-750.00M |
| Common Stock Repurchase | $-138.49M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MSCI | CME |
|---|---|---|
| Shares Short | 1.25M | 5.42M |
| Short Ratio | 1.46 | 2.53 |
| Short % of Float | 0.02% | 0.02% |
| Average Daily Volume (10 Day) | 642,820 | 1,887,200 |
| Average Daily Volume (90 Day) | 861,290 | 2,111,473 |
| Shares Outstanding | 77.74M | 359.61M |
| Float Shares | 74.70M | 358.78M |
| % Held by Insiders | 0.03% | 0.00% |
| % Held by Institutions | 0.95% | 0.92% |
Dividend Analysis & Yield Comparison: MSCI vs CME
| Metric | MSCI | CME |
|---|---|---|
| Last 12-Month Dividend | $5.00 | $11.85 |
| Last 12-Month Dividend Yield | 0.92% | 4.30% |
| 3-Year Avg Annual Dividend | $5.41 | $10.10 |
| 3-Year Avg Dividend Yield | 0.27% | 0.91% |
| 3-Year Total Dividends | $16.22 | $30.30 |
| Ex-Dividend Date | Feb 14, 2025 | Sep 09, 2025 |